HIV-infected children vaccination coverage and safety in a Western European cohort: a retrospective study.
Identifieur interne : 000571 ( Main/Exploration ); précédent : 000570; suivant : 000572HIV-infected children vaccination coverage and safety in a Western European cohort: a retrospective study.
Auteurs : María Fernández-Ibieta [Espagne] ; José T. Ramos-Amador ; Ismael Au N-MartínSource :
- International journal of STD & AIDS [ 0956-4624 ] ; 2007.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Calendrier vaccinal (MeSH), Enfant (MeSH), Enfant d'âge préscolaire (MeSH), Espagne (MeSH), Humains (MeSH), Infections à VIH (complications), Infections à VIH (immunologie), Nourrisson (MeSH), Observance par le patient (MeSH), Population urbaine (MeSH), Vaccination de masse (statistiques et données numériques), Vaccins (administration et posologie), Études de cohortes (MeSH), Études rétrospectives (MeSH).
- MESH :
- administration et posologie : Vaccins.
- immunologie : Infections à VIH.
- statistiques et données numériques : Vaccination de masse.
- complications : Adolescent, Adulte, Calendrier vaccinal, Enfant, Enfant d'âge préscolaire, Espagne, Humains, Infections à VIH, Nourrisson, Observance par le patient, Population urbaine, Études de cohortes, Études rétrospectives.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Child (MeSH), Child, Preschool (MeSH), Cohort Studies (MeSH), HIV Infections (complications), HIV Infections (immunology), Humans (MeSH), Immunization Schedule (MeSH), Infant (MeSH), Mass Vaccination (statistics & numerical data), Patient Compliance (MeSH), Retrospective Studies (MeSH), Spain (MeSH), Urban Population (MeSH), Vaccines (administration & dosage).
- MESH :
- chemical , administration & dosage : Vaccines.
- complications : HIV Infections.
- immunology : HIV Infections.
- statistics & numerical data : Mass Vaccination.
- Adolescent, Adult, Child, Child, Preschool, Cohort Studies, Humans, Immunization Schedule, Infant, Patient Compliance, Retrospective Studies, Spain, Urban Population.
Abstract
Since the implementation of highly active antiretroviral therapy in HIV-infected children, response to scheduled vaccines may determinate future morbidity and mortality. The aims of this study have been to describe the current vaccine coverage, vaccine safety and concordance with vaccine recommendations of the 68 HIV-infected children and adolescents followed up in our Unit. Forty-four percent of the children received at least one dose of the oral polio vaccine (OPV). Only 9.1% needed and received a second set of hepatitis B virus immunization because of low vaccine response. Only 14.7% were vaccinated against varicella. Coverages of 82.3% and 100% have been reached with the 23-valent and the 7-valent pneumococcal vaccines, respectively. Meningococcal conjugated vaccine uptake was moderate (80.8%). Influenza annual vaccination coverage was poor: only 22.7% had well-documented yearly vaccines. In our experience, vaccine coverage is lower in those vaccines administered in primary care centres compared with the immunizations given at the hospital. OPV administration did not cause any adverse effect in the children or in their families. Vaccine coverage in HIV-infected children was suboptimal.
DOI: 10.1258/095646207780749763
PubMed: 17524201
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">HIV-infected children vaccination coverage and safety in a Western European cohort: a retrospective study.</title><author><name sortKey="Fernandez Ibieta, Maria" sort="Fernandez Ibieta, Maria" uniqKey="Fernandez Ibieta M" first="María" last="Fernández-Ibieta">María Fernández-Ibieta</name><affiliation wicri:level="2"><nlm:affiliation>Immunodeficiency Unit, Paediatric Department, Hospital 12 de Octubre, Ctra. Andalucia s/n Madrid 28014, Spain. mfndezibieta@hotmail.com</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Immunodeficiency Unit, Paediatric Department, Hospital 12 de Octubre, Ctra. Andalucia s/n Madrid 28014</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Ramos Amador, Jose T" sort="Ramos Amador, Jose T" uniqKey="Ramos Amador J" first="José T" last="Ramos-Amador">José T. Ramos-Amador</name></author><author><name sortKey="Au N Martin, Ismael" sort="Au N Martin, Ismael" uniqKey="Au N Martin I" first="Ismael" last="Au N-Martín">Ismael Au N-Martín</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:17524201</idno><idno type="pmid">17524201</idno><idno type="doi">10.1258/095646207780749763</idno><idno type="wicri:Area/Main/Corpus">00566</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00566</idno><idno type="wicri:Area/Main/Curation">000566</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000566</idno><idno type="wicri:Area/Main/Exploration">000566</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">HIV-infected children vaccination coverage and safety in a Western European cohort: a retrospective study.</title><author><name sortKey="Fernandez Ibieta, Maria" sort="Fernandez Ibieta, Maria" uniqKey="Fernandez Ibieta M" first="María" last="Fernández-Ibieta">María Fernández-Ibieta</name><affiliation wicri:level="2"><nlm:affiliation>Immunodeficiency Unit, Paediatric Department, Hospital 12 de Octubre, Ctra. Andalucia s/n Madrid 28014, Spain. mfndezibieta@hotmail.com</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Immunodeficiency Unit, Paediatric Department, Hospital 12 de Octubre, Ctra. Andalucia s/n Madrid 28014</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Ramos Amador, Jose T" sort="Ramos Amador, Jose T" uniqKey="Ramos Amador J" first="José T" last="Ramos-Amador">José T. Ramos-Amador</name></author><author><name sortKey="Au N Martin, Ismael" sort="Au N Martin, Ismael" uniqKey="Au N Martin I" first="Ismael" last="Au N-Martín">Ismael Au N-Martín</name></author></analytic><series><title level="j">International journal of STD & AIDS</title><idno type="ISSN">0956-4624</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Child (MeSH)</term><term>Child, Preschool (MeSH)</term><term>Cohort Studies (MeSH)</term><term>HIV Infections (complications)</term><term>HIV Infections (immunology)</term><term>Humans (MeSH)</term><term>Immunization Schedule (MeSH)</term><term>Infant (MeSH)</term><term>Mass Vaccination (statistics & numerical data)</term><term>Patient Compliance (MeSH)</term><term>Retrospective Studies (MeSH)</term><term>Spain (MeSH)</term><term>Urban Population (MeSH)</term><term>Vaccines (administration & dosage)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Calendrier vaccinal (MeSH)</term><term>Enfant (MeSH)</term><term>Enfant d'âge préscolaire (MeSH)</term><term>Espagne (MeSH)</term><term>Humains (MeSH)</term><term>Infections à VIH (complications)</term><term>Infections à VIH (immunologie)</term><term>Nourrisson (MeSH)</term><term>Observance par le patient (MeSH)</term><term>Population urbaine (MeSH)</term><term>Vaccination de masse (statistiques et données numériques)</term><term>Vaccins (administration et posologie)</term><term>Études de cohortes (MeSH)</term><term>Études rétrospectives (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Vaccines</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Mass Vaccination</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Vaccination de masse</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Child</term><term>Child, Preschool</term><term>Cohort Studies</term><term>Humans</term><term>Immunization Schedule</term><term>Infant</term><term>Patient Compliance</term><term>Retrospective Studies</term><term>Spain</term><term>Urban Population</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Calendrier vaccinal</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Espagne</term><term>Humains</term><term>Infections à VIH</term><term>Nourrisson</term><term>Observance par le patient</term><term>Population urbaine</term><term>Études de cohortes</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Since the implementation of highly active antiretroviral therapy in HIV-infected children, response to scheduled vaccines may determinate future morbidity and mortality. The aims of this study have been to describe the current vaccine coverage, vaccine safety and concordance with vaccine recommendations of the 68 HIV-infected children and adolescents followed up in our Unit. Forty-four percent of the children received at least one dose of the oral polio vaccine (OPV). Only 9.1% needed and received a second set of hepatitis B virus immunization because of low vaccine response. Only 14.7% were vaccinated against varicella. Coverages of 82.3% and 100% have been reached with the 23-valent and the 7-valent pneumococcal vaccines, respectively. Meningococcal conjugated vaccine uptake was moderate (80.8%). Influenza annual vaccination coverage was poor: only 22.7% had well-documented yearly vaccines. In our experience, vaccine coverage is lower in those vaccines administered in primary care centres compared with the immunizations given at the hospital. OPV administration did not cause any adverse effect in the children or in their families. Vaccine coverage in HIV-infected children was suboptimal.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17524201</PMID><DateCompleted><Year>2007</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0956-4624</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>5</Issue><PubDate><Year>2007</Year><Month>May</Month></PubDate></JournalIssue><Title>International journal of STD & AIDS</Title><ISOAbbreviation>Int J STD AIDS</ISOAbbreviation></Journal><ArticleTitle>HIV-infected children vaccination coverage and safety in a Western European cohort: a retrospective study.</ArticleTitle><Pagination><MedlinePgn>351-3</MedlinePgn></Pagination><Abstract><AbstractText>Since the implementation of highly active antiretroviral therapy in HIV-infected children, response to scheduled vaccines may determinate future morbidity and mortality. The aims of this study have been to describe the current vaccine coverage, vaccine safety and concordance with vaccine recommendations of the 68 HIV-infected children and adolescents followed up in our Unit. Forty-four percent of the children received at least one dose of the oral polio vaccine (OPV). Only 9.1% needed and received a second set of hepatitis B virus immunization because of low vaccine response. Only 14.7% were vaccinated against varicella. Coverages of 82.3% and 100% have been reached with the 23-valent and the 7-valent pneumococcal vaccines, respectively. Meningococcal conjugated vaccine uptake was moderate (80.8%). Influenza annual vaccination coverage was poor: only 22.7% had well-documented yearly vaccines. In our experience, vaccine coverage is lower in those vaccines administered in primary care centres compared with the immunizations given at the hospital. OPV administration did not cause any adverse effect in the children or in their families. Vaccine coverage in HIV-infected children was suboptimal.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fernández-Ibieta</LastName><ForeName>María</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Immunodeficiency Unit, Paediatric Department, Hospital 12 de Octubre, Ctra. Andalucia s/n Madrid 28014, Spain. mfndezibieta@hotmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos-Amador</LastName><ForeName>José T</ForeName><Initials>JT</Initials></Author><Author ValidYN="Y"><LastName>Auñón-Martín</LastName><ForeName>Ismael</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J STD AIDS</MedlineTA><NlmUniqueID>9007917</NlmUniqueID><ISSNLinking>0956-4624</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007115" MajorTopicYN="N">Immunization Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032541" MajorTopicYN="N">Mass Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010349" MajorTopicYN="N">Patient Compliance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014505" MajorTopicYN="N">Urban Population</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="N">Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>5</Month><Day>26</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>7</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>5</Month><Day>26</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17524201</ArticleId><ArticleId IdType="doi">10.1258/095646207780749763</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Communauté de Madrid</li></region></list><tree><noCountry><name sortKey="Au N Martin, Ismael" sort="Au N Martin, Ismael" uniqKey="Au N Martin I" first="Ismael" last="Au N-Martín">Ismael Au N-Martín</name><name sortKey="Ramos Amador, Jose T" sort="Ramos Amador, Jose T" uniqKey="Ramos Amador J" first="José T" last="Ramos-Amador">José T. Ramos-Amador</name></noCountry><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Fernandez Ibieta, Maria" sort="Fernandez Ibieta, Maria" uniqKey="Fernandez Ibieta M" first="María" last="Fernández-Ibieta">María Fernández-Ibieta</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000571 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000571 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:17524201
|texte= HIV-infected children vaccination coverage and safety in a Western European cohort: a retrospective study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:17524201" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |